Citadel Advisors’s Endava DAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$185K Sell
41,900
-58,200
-58% -$321K ﹤0.01% 11483
2025
Q4
$633K Sell
100,100
-98,900
-50% -$757K ﹤0.01% 8449
2025
Q3
$1.81M Buy
199,000
+110,300
+124% +$1.37M ﹤0.01% 6280
2025
Q2
$1.36M Buy
88,700
+60,200
+211% +$1.01M ﹤0.01% 6456
2025
Q1
$556K Buy
28,500
+14,000
+97% +$388K ﹤0.01% 8253
2024
Q4
$448K Sell
14,500
-12,200
-46% -$334K ﹤0.01% 8809
2024
Q3
$682K Sell
26,700
-8,900
-25% -$267K ﹤0.01% 7597
2024
Q2
$1.04M Buy
35,600
+13,400
+60% +$398K ﹤0.01% 6496
2024
Q1
$844K Buy
22,200
+17,500
+372% +$1.05M ﹤0.01% 7289
2023
Q4
$366K Sell
4,700
-600
-11% -$37.1K ﹤0.01% 8744
2023
Q3
$304K Sell
5,300
-7,600
-59% -$396K ﹤0.01% 9148
2023
Q2
$668K Buy
12,900
+5,000
+63% +$269K ﹤0.01% 7289
2023
Q1
$531K Buy
7,900
+6,500
+464% +$510K ﹤0.01% 8175
2022
Q4
$107K Sell
1,400
-20,400
-94% -$1.52M ﹤0.01% 11120
2022
Q3
$1.76M Buy
21,800
+12,100
+125% +$1.15M ﹤0.01% 5830
2022
Q2
$856K Sell
9,700
-28,900
-75% -$3.02M ﹤0.01% 7377
2022
Q1
$5.13M Buy
38,600
+3,600
+10% +$453K ﹤0.01% 4117
2021
Q4
$5.88M Buy
35,000
+28,700
+456% +$4.45M ﹤0.01% 4021
2021
Q3
$856K Buy
+6,300
New +$813K ﹤0.01% 8534

Other funds holding DAVA

Citadel Advisors's DAVA Position: Q4 2025 in Review

Citadel Advisors sold out of Endava (DAVA) in Q4 2025, closing a stake of 389,269 shares — an estimated $2.98M sold.

Citadel Advisors first reported a position in DAVA in Q3 2018 and held it in 26 quarters. The position peaked at $30.1M in Q3 2022. 101 funds tracked by Wall St. Rank hold DAVA as of Q4 2025.

  • Citadel Advisors reported no remaining Endava position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 389,269 Endava shares in Q4 2025, an estimated $2.98M.
  • Citadel Advisors first reported a position in Endava in Q3 2018 and held it in 26 quarters.
  • Citadel Advisors's Endava position peaked at $30.1M in Q3 2022.
  • 101 funds tracked by Wall St. Rank held Endava as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.